Small Bifunctional Chelators That Do Not Disaggregate Amyloid β Fibrils Exhibit Reduced Cellular Toxicity
Open accessAbstract
Multifunctional metal chelators that can modulate the amyloid β (Aβ) peptide aggregation and its interaction with metal ions such as copper and zinc hold considerable promise as therapeutic agents for Alzheimer’s disease (AD). However, specific rather than systemic metal chelation by these compounds is needed in order to limit any side effects. Reported herein are two novel small bifunctional chelators, 2-[2-hydroxy-4-(diethylamino)phenyl]benzothiazole (L1) and 2-(2-hydroxy-3-methoxyphenyl)benzothiazole (L2), in which the metal-binding donor atoms are integrated within a molecular framework derived from the amyloid-binding fluorescent dye thioflavin T (ThT). The metal-binding properties of L1 and L2 were probed by pH spectrophotometric titrations to determine their pKa values and the corresponding metal complex stability constants, and the isolated metal complexes were structurally characterized. The amyloid-fibril-binding properties of L1 and L2 were investigated by fluorescence titrations and ThT competition assays. Interestingly, L1 and L2 do not lead to the formation of neurotoxic Aβ42 oligomers in the presence or absence of metal ions, as observed by native gel electrophoresis, Western blotting, and transmission electron microscopy. In addition, L1 and L2 were able to reduce the cell toxicity of preformed Aβ42 oligomers and of the copper-stabilized Aβ42 oligomers. Given their ability to reduce the toxicity of soluble Aβ42 and Cu-Aβ42 species, L1 and L2 are promising lead compounds for the development of chemical agents that can control the neurotoxicity of soluble Aβ42 species in AD.
AI snapshot
Written from the paper’s full text.
TL;DR
Two small bifunctional chelators, L1 and L2, were designed to bind both metal ions and amyloid β (Aβ) fibrils without disaggregating them. They reduced the cellular toxicity of preformed Aβ42 oligomers and copper-stabilized Aβ42 oligomers in N2A cells.
Key findings
- L1 and L2 bind Aβ fibrils with moderate to strong affinity: L1 gave a Kd of 4.70 ± 0.30 μM and a ThT-competition Ki of 260 ± 40 nM; L2 gave a Ki of 15 ± 10 nM.
- L1 pKa values were 3.556(2), 8.427(3), and 10.108(2); L2 pKa values were 3.154(2) and 9.360(1). L1 binds Cu2+ with log stability constants of 11.99(2) for ML and 20.99(2) for ML2, with pCu values of 6.7 at pH 6.6 and 8.2 at pH 7.4.
- L1 and L2 did not promote formation of soluble Aβ42 oligomers in the presence or absence of metal ions; with Cu2+ they promoted formation of larger insoluble Aβ42 aggregates, and they did not appreciably disaggregate preformed Aβ42 fibrils.
- In N2A cells, preformed Aβ42 oligomers reduced survival to 45 ± 6%; addition of L1 or L2 restored viability to 100 ± 15% and 103 ± 15%, respectively, including in the presence of Cu2+. Clioquinol with Aβ42 fibrils plus Cu2+ gave only 26 ± 3% survival.
Methods
- L1 and L2 were synthesized and characterized by NMR, UV–vis, ESI-MS, elemental analysis, pH spectrophotometric titrations, Job’s plots, and X-ray crystallography of Cu2+ and Zn2+ complexes.
- Aβ fibril binding was measured by fluorescence titrations and ThT competition assays using Aβ40 fibrils; Aβ42 aggregation, inhibition, and disaggregation were assessed by ThT fluorescence, native gel electrophoresis/Western blotting, and TEM.
- Cytotoxicity was measured in mouse neuroblastoma N2A cells using the Alamar Blue assay with 20 μM Aβ42 species, compounds, and metals, after 40 h incubation.
Limitations
- Stated in the paper: Zn2+ stability constants could not be determined because L1 and L2 showed almost no spectral changes with Zn2+ and did not compete significantly with zincon; L2–Cu2+ titration was limited by few spectral changes at micromolar concentrations and precipitation at higher concentrations; pure zinc complexes of L1 or L2 could not be isolated for complete characterization.
- Stated in the paper: the work is in vitro, and in vivo studies are described as ongoing; no in vivo efficacy or toxicity data are reported.
- Evident from the text: Aβ40 was used for fibril-binding assays while Aβ42 was used for aggregation and toxicity studies, and the Aβ40 aggregation results were noted to be less informative because of the lack of appreciable soluble Aβ oligomer formation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
40 of 85 cited sources checked · 23 supported · 0 flagged · accuracy not yet measured
- Premisecitation
Soluble Aβ oligomers are more neurotoxic than insoluble aggregates both in vitro and in vivo.
“recent studies have shown that the soluble Aβ oligomers are more neurotoxic both in vitro and in vivo.5−8”
Quote in the paperSubstantial claim1 of 4 sources checked- cites [5] Walsh, 2007, J. Neurochem. source
In “Detection and toxicity of non-fibrillar assemblies of synthetic Aβ” (page not provided), the review reports that oligomers caused substantially faster and greater neuronal death in culture than fibrillar Aβ. It also describes brain dysfunction caused by soluble oligomers in animals in “Aβ self-association is required for toxicity” (page not provided), but does not establish that they are more neurotoxic than insoluble aggregates in vivo. (LLM, conf=0.83)
Experimental — accuracy not yet measured - cites [6] Haass, 2007, Nat. Rev. Mol. Cell Biol. source
- cites [7] Lambert, 1998, Proc. Natl. Acad. Sci. U.S.A. source
- cites [8] Gong, 2003, Proc. Natl. Acad. Sci. U.S.A. source
- Premisecitation
Molecules having log BB values higher than −0.3 are generally expected to cross the BBB.
“Molecules having log BB values higher than −0.3 are generally expected to cross the BBB.33”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [33] Rodriguez-Rodriguez, 2009, J. Am. Chem. Soc. source
- Interpretationcitation
The approach of inhibiting metal-mediated Aβ40 aggregation or promoting disaggregation may not be optimal for the Aβ42 peptide, given the increased toxicity observed for soluble Aβ42 oligomers.
“However, this approach may not be optimal for the Aβ42 peptide, given the increased toxicity observed for soluble Aβ42 oligomers.20,21”
Quote in the paperSubstantial claim2 of 2 sources checked - Findingcitation
The presence of Cu2+ ions inhibits the formation of large soluble and insoluble Aβ42 aggregates.
“the presence of Cu2+ ions inhibits the formation of large soluble and insoluble Aβ42 aggregates (Figure 7, lane 2).”
Quote in the paperNot a substantial claim2 of 2 sources checked- cites [20] Sharma, 2012, J. Am. Chem. Soc. source
In Results and Discussion, ‘Effect of L1 and L2 on Aβ42 Aggregation’ (page unavailable), the paper reports almost no fibrils after 24 hours in the presence of Cu, supporting inhibition of large insoluble aggregates. It also reports soluble Aβ42 oligomers of 10–110 kDa and says metal ions stabilize soluble oligomers, so it does not support inhibition of large soluble aggregates. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [21] Sharma, 2013, Metallomics source
- Premisecitation
Cu2+-Aβ species have been shown to be neurotoxic.
“Because Cu2+–Aβ species have been shown to be neurotoxic,20,21,31,51,52”
Quote in the paperSubstantial claim4 of 5 sources checked
- Findingcitation
In inhibition experiments, reduced ThT fluorescence was observed for Cu2+- and Zn2+-containing fibrils.
“In inhibition experiments, a reduced ThT fluorescence was observed for the Cu2+- and Zn2+-containing fibrils, as reported previously (Figure 6).21,49,50”
Quote in the paperNot a substantial claim3 of 3 sources checked- cites [21] Sharma, 2013, Metallomics source
The Introduction and the Results and discussion section on ThT fluorescence report reduced fluorescence for Aβ42 aggregates prepared with Cu2+ and Zn2+. They do not establish that the measured material was fibrils: the paper says the metals inhibit fibrillization, with Zn2+ promoting amorphous aggregates and Cu2+ stabilizing soluble species. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [49] Mold, 2013, Sci. Rep. source
The Results (page unavailable) report significantly lower ThT fluorescence in Aβ42 preparations with added Cu(II), supporting the copper portion of the claim. The paper does not report a corresponding Zn(II) inhibition experiment, so it does not support the zinc portion. (LLM, conf=0.88)
Experimental — accuracy not yet measured - cites [50] House, 2009, J. Alzheimer’s Dis. source
The Results report reduced ThT fluorescence after Cu(II) was added to preformed Aβ42 aggregates, and the Methods describe those assays. The paper does not report a corresponding Zn(II) result; its experiments tested copper, including with aggregates formed in the presence of aluminum. Thus this source supports the copper part of the claim, but not the zinc part. (LLM, conf=0.89)
Experimental — accuracy not yet measured
- Premisecitation
Aβ42 peptide was shown to form neurotoxic soluble Aβ oligomers.
“the Aβ42 peptide was employed in these studies because it was shown to form neurotoxic soluble Aβ oligomers.5,8,48”
Quote in the paperSubstantial claim1 of 3 sources checked - Premisecitation
BFCs with high affinity for both metal ions and Aβ fibrils can cause significant oligomerization via disaggregation of Aβ42 fibrils and lead to enhanced neurotoxicity.
“We have previously shown that BFCs, which have high affinity for both metal ions and Aβ fibrils, can cause significant oligomerization via disaggregation of Aβ42 fibrils and lead to enhanced neurotoxicity.20”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [20] Sharma, 2012, J. Am. Chem. Soc. source
- Findingown data
For preformed Aβ42 fibrils, no significant cell toxicity was observed in either the absence or presence of Cu2+.
“For the preformed Aβ42 fibrils, no significant cell toxicity was observed in either the absence or presence of Cu2+ (Figure 9, lanes 1 and 2), supporting the previously reported diminished toxicity of Aβ42 fibrils.5,7,54−56”
Quote in the paperSubstantial claim3 of 5 sources checked- cites [5] Walsh, 2007, J. Neurochem. source
In “Detection and toxicity of non-fibrillar assemblies of synthetic Aβ” (page not provided), the review reports that fibrillar Aβ caused only modest cell death at a higher concentration and after a longer exposure than oligomers. This supports the cited background point that fibrils have diminished toxicity, but it does not report the citing paper’s specific finding of no significant toxicity from preformed Aβ42 fibrils with or without Cu2+. (LLM, conf=0.85)
Experimental — accuracy not yet measured - cites [7] Lambert, 1998, Proc. Natl. Acad. Sci. U.S.A. source
- cites [54] Hsia, 1999, Proc. Natl. Acad. Sci. U.S.A. source
The Results and Discussion report that neuronal deficits in mice occurred without extracellular fibrillar Aβ deposits. That does not establish diminished toxicity of preformed Aβ42 fibrils. Our copy does not report a cell-toxicity comparison of preformed fibrils with and without Cu2+ (searched: preformed fibrils, Cu2+, diminished toxicity). (LLM, conf=0.76)
Experimental — accuracy not yet measured - cites [55] Lesne, 2006, Nature source
- cites [56] Ahmed, 2011, Nat. Struct. Mol. Biol. source
- Findingown data
Even in the presence of Cu2+, L1 and L2 were able to eliminate the neurotoxicity of soluble Aβ42 oligomers.
“Even in the presence of Cu2+, which has been shown to stabilize the soluble Aβ42 oligomers,22 L1 and L2 were able to eliminate the neurotoxicity of soluble Aβ42 oligomers (Figure 9, lanes 9 and 10).”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [22] Zhang, 2013, Proc. Natl. Acad. Sci. U.S.A. source
- Findingown data
L1 and L2 do not lead to the formation of neurotoxic Aβ42 oligomers in the presence or absence of metal ions.
“Interestingly, L1 and L2 do not lead to the formation of neurotoxic Aβ42 oligomers in the presence or absence of metal ions, as observed by native gel electrophoresis, Western blotting, and transmission electron microscopy.”
Quote in the paperSubstantial claim - Findingnone given
L1 and L2 have a modified 2-(2-hydroxyphenyl)benzothiazole (HPB) molecular framework reminiscent of the amyloid-binding fluorescent dye ThT.
“L1 and L2 have a modified 2-(2-hydroxyphenyl)benzothiazole (HPB) molecular framework reminiscent of the amyloid-binding fluorescent dye ThT (Scheme 1)”
Quote in the paperNot a substantial claim - Findingown data
L1 and L2 promote Aβ42 aggregation in the presence of metal ions.
“yet they promote aggregation in the presence of metal ions, as observed by native gel/Western blotting and TEM.”
Quote in the paperSubstantial claim - Findingown data
L2 binds very strongly to Aβ fibrils with a Ki of 15 nM.
“L2 binds very strongly to Aβ fibrils with a Ki of 15 nM.”
Quote in the paperSubstantial claim - Findingown data
L1 and L2 moderately inhibit Aβ42 aggregation in the absence of metal ions.
“L1 and L2 moderately inhibit Aβ42 aggregation in the absence of metal ions”
Quote in the paperNot a substantial claim - Findingown data
The bifunctional character of L1 and L2 was confirmed by metal-chelating and Aβ-binding studies.
“The bifunctional character of the two compounds was confirmed by metal-chelating and Aβ-binding studies.”
Quote in the paperSubstantial claim - Findingown data
In the presence of Zn2+ and either L1 or L2, almost no effect on ThT fluorescence intensity is observed.
“the presence of Zn2+ and either L1 or L2 shows almost no effect on the ThT fluorescence intensity”
Quote in the paperSubstantial claim - Findingown data
L1 binds Cu2+ with a stability constant of 11.99(2) for the M + L = ML equilibrium.
“L1 binds Cu2+ with a stability constant of 11.99(2) for the M + L = ML equilibrium”
Quote in the paperNot a substantial claim - Findingcitation
For L1-Cu2+, a break in the Job's plot at 0.4 mole fraction of Cu2+ suggests the formation of both 1:1 and 2:1 L1-Cu2+ complexes in solution.
“For L1–Cu2+, a break in the plot at 0.4 mole fraction of Cu2+ suggests the formation of both 1:1 and 2:1 L1–Cu2+ complexes in solution (Figure S4 in the SI).40”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingown data
The presence of either L1 or L2 does not dramatically affect the formation of insoluble Aβ42 aggregates in the presence of Zn2+.
“the presence of either L1 or L2 does not dramatically affect the formation of insoluble Aβ42 aggregates in the presence of Zn2+ (Figure 7, panels 6 and 9)”
Quote in the paperSubstantial claim - Findingown data
Native gel/Western blotting analysis reveals bands at the top of the gel, suggesting the presence of insoluble Aβ42 aggregates, which were not observed in the presence of Cu2+ alone.
“native gel/Western blotting analysis reveals bands at the top of the gel, suggesting the presence of insoluble Aβ42 aggregates (Figure 7, lanes 5 and 8), which were not observed in the presence of Cu2+ alone (Figure 7, lane 2).”
Quote in the paperSubstantial claim - Findingown data
Native gel/Western blotting analysis reveals a limited effect of L1 and L2 on Aβ42 aggregation.
“Native gel/Western blotting analysis reveals a limited effect of L1 and L2 on Aβ42 aggregation (Figure 7, lanes 4 and 7).”
Quote in the paperSubstantial claim - Findingown data
In the presence of Cu2+ and either L1 or L2, a very low ThT fluorescence intensity is observed.
“In the presence of Cu2+ and either L1 or L2, a very low ThT fluorescence intensity is observed”
Quote in the paperSubstantial claim - Findingown data
Aβ42 aggregation in the presence of Cu2+ shows the formation of a dramatically reduced number of Aβ42 fibrils.
“Aβ42 aggregation in the presence of Cu2+ shows the formation of a dramatically reduced number of Aβ42 fibrils (Figure 7, panel 2)”
Quote in the paperSubstantial claim - Findingown data
Aβ42 peptide forms well-defined Aβ42 fibrils, as confirmed by TEM.
“the Aβ42 peptide forms well-defined Aβ42 fibrils, as confirmed by TEM (Figure 7, panel 1)”
Quote in the paperSubstantial claim - Findingown data
L1 and L2 do not compete significantly with zincon for zinc binding, even when present in large excess versus zincon.
“L1 and L2 do not compete significantly with zincon for zinc binding, even when present in large excess versus zincon”
Quote in the paperNot a substantial claim - Findingown data
Aggregation of Aβ42 in the presence of Zn2+ leads to the formation of large amorphous aggregates.
“aggregation of Aβ42 in the presence of Zn2+ leads to the formation of large amorphous aggregates (Figure 7, panel 3)”
Quote in the paperNot a substantial claim - Findingown data
TEM analysis shows that Aβ40 forms well-defined fibrils either in the absence or presence of L1 or L2.
“TEM analysis shows that Aβ40 forms well-defined fibrils either in the absence or presence of L1 or L2 (Figure S9 in the SI, panels 1 and 4).”
Quote in the paperSubstantial claim - Findingown data
Addition of zincon to solutions of Zn-L1 and Zn-L2 complexes results in quantitative formation of the Zn-zincon complex.
“the addition of zincon to solutions of Zn–L1 and Zn–L2 complexes results in quantitative formation of the Zn–zincon complex”
Quote in the paperSubstantial claim - Findingown data
In the presence of Zn2+, either L1 or L2 seems to have a limited effect on the morphology of the insoluble Aβ42 aggregates.
“In the presence of Zn2+, either L1 or L2 seems to have a limited effect on the morphology of the insoluble Aβ42 aggregates, as observed by both TEM and Western blotting (Figure 8, panels/lanes 6 and 9).”
Quote in the paperSubstantial claim - Findingown data
L1 binds Cu2+ with a stability constant of 20.99(2) for the ML + L = ML2 equilibrium.
“a value of 20.99(2) for the ML + L = ML2 equilibrium”
Quote in the paperNot a substantial claim - Findingown data
Preformed soluble Aβ42 oligomers show a limited cell survival of 45 ± 6%.
“the preformed soluble Aβ42 oligomers show a limited cell survival of 45 ± 6% (Figure 9, lane 8).”
Quote in the paperSubstantial claim - Findingown data
Compounds L1 and L2 do not affect the cell viability when added to N2A cells in the presence of preformed Aβ42 fibrils.
“compounds L1 and L2 do not affect the cell viability when added to the N2A cells in the presence of preformed Aβ42 fibrils (Figure 9, lanes 3 and 4).”
Quote in the paperSubstantial claim - Findingown data
Even in the presence of preformed Aβ42 fibrils and Cu2+, the cell viability is not affected by either L1 or L2.
“Even in the presence of preformed Aβ42 fibrils and Cu2+, the cell viability is not affected by either L1 or L2 (Figure 9, lanes 5 and 6).”
Quote in the paperSubstantial claim - Findingown data
CQ shows quite high cell toxicity to cells in the presence of Cu2+ and Aβ42 fibrils with a cell survival of only 26 ± 3%.
“CQ shows quite high cell toxicity to cells in the presence of Cu2+ and Aβ42 fibrils with a cell survival of only 26 ± 3% (Figure 9, lane 7).”
Quote in the paperSubstantial claim - Findingown data
Addition of either L1 or L2 to N2A cells along with preformed Aβ42 oligomers drastically reduces the neurotoxicity of soluble Aβ42 species to 100 ± 15% and 103 ± 15% cell viability, respectively.
“the addition of either L1 or L2 to the N2A cells along with the preformed Aβ42 oligomers drastically reduces the neurotoxicity of soluble Aβ42 species to 100 ± 15% and 103 ± 15% cell viability, respectively (Figure 9, lanes 9 and 10).”
Quote in the paperSubstantial claim - Interpretationreasoning
L1 replaces ThT only from the higher affinity binding site.
“As such, we propose that L1 replaces ThT only from the higher affinity binding site.”
Quote in the paperNot a substantial claim - Interpretationown data
The presence of either L1 or L2, in both the presence or absence of metal ions, does not promote the formation of soluble Aβ42 oligomers.
“Overall, these studies suggest that the presence of either L1 or L2, in both the presence or absence of metal ions, does not promote the formation of soluble Aβ42 oligomers.”
Quote in the paperSubstantial claim - Premisecitation
Zincon exhibits a Kd ≈ 10 μM for zinc.
“exhibits a Kd ≈ 10 μM for zinc.44”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [44] Talmard, 2007, Biochemistry source
- Interpretationown data
Compounds L1 and L2 reduce the amount of soluble Aβ42 oligomers formed in the presence of Cu2+ by promoting the formation of insoluble Aβ42 aggregates.
“Thus, compounds L1 and L2 reduce the amount of soluble Aβ42 oligomers formed in the presence of Cu2+ by promoting the formation of insoluble Aβ42 aggregates.”
Quote in the paperSubstantial claim - Premisecitation
Both compounds L1 and L2 contain a 2-phenylbenzothiazole fragment reminiscent of the fluorescent dye ThT used to detect the β-sheet structure of fibrillar Aβ aggregates.
“Both compounds L1 and L2 contain a 2-phenylbenzothiazole fragment reminiscent of the fluorescent dye ThT used to detect the β-sheet structure of fibrillar Aβ aggregates.45,46”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationown data
L1 and L2 exhibit affinities for zinc that are at least 10 times lower than that of zincon.
“suggesting that they exhibit affinities for zinc that are at least 10 times lower than that of zincon”
Quote in the paperSubstantial claim - Interpretationown data
The pKa values of L2 can be assigned to deprotonation of the nitrogen atoms of the benzothiazole and phenol groups, respectively.
“These pKa values can be assigned to deprotonation of the nitrogen atoms of the benzothiazole and phenol groups, respectively.”
Quote in the paperNot a substantial claim - Interpretationown data
These cellular toxicity data suggest that L1 and L2 do not lead to any cell toxicity in the presence or absence of Aβ42 fibrils and Cu2+ ions.
“Thus, these cellular toxicity data suggest that L1 and L2 do not lead to any cell toxicity in the presence or absence of Aβ42 fibrils and Cu2+ ions”
Quote in the paperSubstantial claim - Interpretationown data
The BFCs described herein promote fibrillization of Cu2+-stabilized soluble Aβ42 oligomers.
“and are having the desired opposite effect of promoting fibrillization of Cu2+-stabilized soluble Aβ42 oligomers”
Quote in the paperSubstantial claim - Interpretationown data
The BFCs described herein drastically reduce the neurotoxicity of soluble Aβ42 species, in both the presence or absence of Cu2+ ions.
“and most importantly they drastically reduce the neurotoxicity of soluble Aβ42 species, in both the presence or absence Cu2+ ions.”
Quote in the paperSubstantial claim - Interpretationown data
The bifunctionality of L1 and L2 (i.e., metal chelation and Aβ interaction) was established through various spectroscopic studies such as spectrophotometric titrations, structural characterization, and fluorescent assays.
“The bifunctionality of L1 and L2 (i.e., metal chelation and Aβ interaction) was established through various spectroscopic studies such as spectrophotometric titrations, structural characterization, and fluorescent assays.”
Quote in the paperSubstantial claim - Interpretationnone given
These BFCs are the first to control the metal-mediated neurotoxicity of Aβ42 oligomers.
“Because, to the best of our knowledge, these BFCs are the first to control the metal-mediated neurotoxicity of Aβ42 oligomers”
Quote in the paperSubstantial claim - Interpretationown data
These cellular toxicity data suggest that L1 and L2 do not disaggregate Aβ42 fibrils to generate neurotoxic soluble Aβ42 species.
“suggesting that these compounds do not disaggregate Aβ42 fibrils to generate neurotoxic soluble Aβ42 species.”
Quote in the paperSubstantial claim - Interpretationown data
These are the first BFCs that reduce the toxicity of soluble Aβ42 oligomers, in both the presence or absence of Cu2+ ions.
“to the best of our knowledge, these are the first BFCs that reduce the toxicity of soluble Aβ42 oligomers, in both the presence or absence of Cu2+ ions.”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 22
- May combine two claims. 49
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationThe longer and more hydrophobic Aβ42 isoform has a higher tendency to generate neurotoxic oligomeric species than Aβ40.
“the longer and more hydrophobic Aβ42 isoform has a higher tendency to generate neurotoxic oligomeric species.9,10”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [9] McGowan, 2005, Neuron source
- cites [10] Kuperstein, 2010, EMBO J. source
The ‘Long-term cellular toxicity of Aβ mixtures’ section reports neurotoxicity from Aβ42 alone but not Aβ40 alone; the discussion links Aβ42-rich preparations to toxic intermediates. This supports the comparative tendency, but our copy does not establish that Aβ42’s greater hydrophobicity explains it, and emphasizes the importance of the Aβ42:Aβ40 ratio. (LLM, conf=0.85)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationWe have recently reported 2-phenylbenzothiazole/vanillin derivatives as BFCs that showed a strong affinity for Aβ fibrils.
“We have also recently reported 2-phenylbenzothiazole/vanillin derivatives as BFCs that showed a strong affinity for Aβ fibrils.20”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [20] Sharma, 2012, J. Am. Chem. Soc. source
May combine two claims.
PremisecitationIn Rodríguez-Rodríguez et al., only solution coordination properties were investigated in detail, while Aβ-binding and antiaggregation properties were only qualitatively evaluated through epifluorescence microscopy and turbidity assays.
“However, in that report, only the solution coordination properties of those compounds were investigated in detail, while the Aβ-binding and antiaggregation properties were only qualitatively evaluated through epifluorecense microscopy and turbidity assays.”
Quote in the paperSubstantial claim1 of 1 sources checked- cites [33] Rodriguez-Rodriguez, 2009, J. Am. Chem. Soc. source
The Fluorescence Microscopy Binding Assays section describes imaging fibrils, and the Figure 10 caption (p. 40) explicitly calls its binding-intensity scale qualitative. The paper also investigates aggregation with turbidity assays, but the Turbidity Measurements section reports repeated, blank-corrected absorbance measurements, and the aggregation discussion gives a numerical result. Thus, describing the antiaggregation evaluation as only qualitative overstates the source. (LLM, conf=0.86)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPreviously, an iodinated HPB and related compounds were shown to have potential as metal-chelating agents by Rodríguez-Rodríguez et al.
“Previously, an iodinated HPB and a few related compounds were shown to have potential as metal-chelating agents by Rodríguez-Rodríguez et al.33”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [33] Rodriguez-Rodriguez, 2009, J. Am. Chem. Soc. source
The Summary (page not available) reports that the iodinated compounds HBXI, HBTI and BMI can chelate Cu(II) and Zn(II), supporting the metal-chelating point. Our copy identifies these compounds as derivatives of HBX, HBT and BM; it does not identify an iodinated compound called HPB. (LLM, conf=0.84)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationCompounds that inhibit metal-mediated Aβ40 aggregation or promote disaggregation of amyloid fibrils lead to increased cell viability.
“Compounds that inhibit metal-mediated Aβ40 aggregation or promote disaggregation of amyloid fibrils were shown to lead to increased cell viability.25,31,32”
Quote in the paperSubstantial claim1 of 3 sources checked- cites [25] Choi, 2010, Proc. Natl. Acad. Sci. U.S.A. source
- cites [31] Hindo, 2009, J. Am. Chem. Soc. source
In the main text (page unavailable), compounds 1 and 2 inhibit Cu-induced Aβ aggregation and disassemble Cu-Aβ fibrils; a separate cell experiment reports that compound 2 reduces Cu-Aβ toxicity, yielding about 90% cell survival. The paper does not establish that aggregation inhibition or fibril disaggregation caused the improved survival, or that the result applies to such compounds generally. Our copy identifies the peptide in these passages as Aβ, not specifically Aβ40. (LLM, conf=0.84)
Experimental — accuracy not yet measured - cites [32] Scott, 2011, Chem. Sci. source
May combine two claims.
PremisecitationCu2+ ions slow down fibrillization of Aβ42 peptide and stabilize soluble Aβ42 species.
“We have also recently reported that Cu2+ ions slow down fibrillization of the Aβ42 peptide and stabilize the soluble Aβ42 species, as observed by native gel electrophoresis/Western blotting, TEM, cell viability studies,20,21 and pulsed hydrogen/deuterium exchange mass spectrometry studies.22”
Quote in the paperNot a substantial claim3 of 3 sources checkedClassified as probably not a substantial claim.
PremisecitationRecent efforts to control abnormal Aβ-metal interactions have focused on small molecules, bifunctional chelators (BFCs), that have binding affinity for both metal ions and Aβ aggregates.
“Recent efforts to control abnormal Aβ–metal interactions have focused on small molecules, bifunctional chelators (BFCs), that have binding affinity for both metal ions and Aβ aggregates.20,25,27−30”
Quote in the paperSubstantial claim2 of 6 sources checked- cites [20] Sharma, 2012, J. Am. Chem. Soc. source
- cites [25] Choi, 2010, Proc. Natl. Acad. Sci. U.S.A. source
- cites [27] Dedeoglu, 2004, Exp. Gerontol. source
- cites [28] Liu, 2013, Inorg. Chem. source
- cites [29] Pithadia, 2012, Curr. Opin. Chem. Biol. source
- cites [30] Pithadia, 2012, Inorg. Chem. source
May combine two claims.
PremisecitationThe majority of these BFCs have been studied for their effect on aggregation of the Aβ40 peptide, and fewer studies have focused on their interaction with the more neurotoxic Aβ42 peptide.
“However, the majority of these BFCs have been studied for their effect on aggregation of the Aβ40 peptide,25,31 and fewer studies have focused on their interaction with the more neurotoxic Aβ42 peptide.20,21”
Quote in the paperSubstantial claim3 of 4 sources checked- cites [25] Choi, 2010, Proc. Natl. Acad. Sci. U.S.A. source
- cites [31] Hindo, 2009, J. Am. Chem. Soc. source
The main text (page unavailable) reports that bifunctional chelators 1 and 2 modulate copper-induced Aβ aggregation, supporting this paper as an example of such a study. It identifies the peptide only as Aβ; our copy does not establish that it was Aβ40 or support the claim that a majority of BFC studies used Aβ40 rather than Aβ42 (searched both peptide names). (LLM, conf=0.78)
Experimental — accuracy not yet measured - cites [20] Sharma, 2012, J. Am. Chem. Soc. source
- cites [21] Sharma, 2013, Metallomics source
The Introduction (page unavailable) says Aβ42 is more neurotoxic than Aβ40, and the Results and discussion section says this study focuses mainly on how Cu2+ and Zn2+ affect Aβ42 aggregation. The cited paper does not establish that fewer studies have examined BFC interactions with Aβ42, nor does it study BFCs itself. (LLM, conf=0.84)
Experimental — accuracy not yet measured
May combine two claims.
PremisecitationMetal chelators reduce metal-mediated Aβ aggregation, ROS formation, and neurotoxicity in vitro.
“metal chelators have been shown to reduce metal-mediated Aβ aggregation, ROS formation, and neurotoxicity in vitro.23−26”
Quote in the paperSubstantial claim1 of 4 sources checkedClassified as probably not a substantial claim.
PremisecitationAβ42 peptide is more prone to form neurotoxic soluble Aβ oligomers than the Aβ40 peptide.
“Although it was shown in previous studies9,10,21 that the Aβ42 peptide is more prone to form neurotoxic soluble Aβ oligomers than the Aβ40 peptide”
Quote in the paperSubstantial claim2 of 3 sources checkedMay combine two claims.
FindingcitationThe presence of Cu2+ and Zn2+ does not inhibit Aβ40 aggregation, yet they change the morphology of the insoluble aggregates that become more amorphous.
“the presence of Cu2+ and Zn2+ does not inhibit Aβ40 aggregation,21 yet they change the morphology of the insoluble aggregates that become more amorphous (Figure S9 in the SI, panels 2 and 3).”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [21] Sharma, 2013, Metallomics source
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe pCu values for Cu-L1 are lower than those for the analogous HPB compound reported previously.
“These pCu values are lower compared to those for the analogous HPB compound reported previously,33”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [33] Rodriguez-Rodriguez, 2009, J. Am. Chem. Soc. source
The metal-binding discussion (section <TABLE 5> <FIGURE 8>, page unavailable) describes pM values for HBXI, HBTI, and BMI, while Table 5 lists their stability constants. Searches for Cu-L1, HPB, and their pCu comparison found no passage addressing whether Cu-L1 has lower pCu values than HPB. (LLM, conf=0.75)
Experimental — accuracy not yet measured
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAβ40 fibrils form more homogeneous fibrillar structures without any nonfibrillar aggregates.
“These studies were performed with Aβ40 fibrils, which form more homogeneous fibrillar structures without any nonfibrillar aggregates.45,47”
Quote in the paperNot a substantial claim1 of 2 sources checked- cites [45] Klunk, 2001, Life Sci. source
- cites [47] Lockhart, 2005, J. Biol. Chem. source
The Materials and Methods section (page not provided) confirms that the authors prepared Aβ40 fibrils. The section on binding constants (page not provided) reports uniformly distributed ligand-binding sites, but also identifies two populations of high-molecular-mass species. It does not establish that the fibrillar structures are more homogeneous or free of nonfibrillar aggregates. (LLM, conf=0.82)
Experimental — accuracy not yet measured
May combine two claims.
InterpretationcitationThe Ki value for L1 is smaller than the Kd value, most likely because ThT binds with different affinities to more than one site on Aβ fibrils.
“It should be noted that the Ki value for L1 is smaller than the Kd value, which is most likely due to the fact that ThT binds with different affinities to more than one site to the Aβ fibrils.47”
Quote in the paperNot a substantial claim1 of 1 sources checked- cites [47] Lockhart, 2005, J. Biol. Chem. source
The Discussion (page unavailable) reports multiple ligand-binding sites on Aβ fibrils and differences between fluorescence- and radioligand-derived binding values, supporting the proposed explanation in general. However, the paper does not report a Ki or Kd for L1 or establish that its particular Ki–Kd difference is caused by ThT binding at sites with different affinities. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
FindingcitationThe clinically tested compound CQ was quite toxic to cells even at 2 μM concentration, while EDTA does not show any toxicity up to 20 μM.
“the clinically tested compound CQ was quite toxic to cells even at 2 μM concentration, while EDTA does not show any toxicity up to 20 μM.25,31”
Quote in the paperSubstantial claim1 of 2 sources checked- cites [25] Choi, 2010, Proc. Natl. Acad. Sci. U.S.A. source
- cites [31] Hindo, 2009, J. Am. Chem. Soc. source
The cell-study passage (page not provided) reports that CQ was more toxic than the paper’s chelators 1 and 2 in the presence of CuII. It does not establish toxicity at 2 μM or report that EDTA was nontoxic up to 20 μM; the stated absence of toxicity up to 200 μM refers to compound 2, not EDTA. (LLM, conf=0.86)
Experimental — accuracy not yet measured
May combine two claims.
Findingown dataThe calculated log BB values for L1 and L2 are +0.33 and +0.087, respectively.
“The calculated log BB values for L1 and L2 are +0.33 and +0.087, respectively”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataBoth L1 and L2 are small in size and satisfy Lipinski's rules for crossing the BBB.
“Both L1 and L2 are small in size, and they also satisfy Lipinski’s rules for crossing the BBB (Table 1).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataL1 and L2 exhibit UV absorption in MeCN at 260 and 380 nm for L1 and at 305 and 345 nm for L2.
“These compounds exhibit UV absorption in MeCN at 260 and 380 nm for L1 and at 305 and 345 nm for L2 (Figures S1 and S2 in the SI).40”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Findingown dataL1 and L2 reduce the cell toxicity of preformed Aβ42 oligomers and of copper-stabilized Aβ42 oligomers.
“In addition, L1 and L2 were able to reduce the cell toxicity of preformed Aβ42 oligomers and of the copper-stabilized Aβ42 oligomers.”
- Also stated in: § Introduction · plain
“In addition, L1 and L2 were able to reduce the cell toxicity of preformed Aβ42 oligomers as well as that of soluble copper-stabilized Aβ42 oligomers, which were shown recently to be neurotoxic.20,21”
Quote in the paperSubstantial claim- Also stated in: § Introduction · plain
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataFor L1, the best fit to the UV-vis titration data was obtained with pKa values of 3.556(2), 8.427(3), and 10.108(2).
“For L1, the best fit to the data was obtained with pKa values of 3.556(2), 8.427(3), and 10.108(2) (Table 2).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
FindingcitationL1 exhibits low-intensity emission at 450 nm and a shoulder at 525 nm, while L2 shows a more intense emission at 525 nm in PBS.
“While both L1 and L2 are 2-phenylbenzothiazole derivatives, L1 exhibits low-intensity emission at 450 nm and a shoulder at 525 nm, yet L2 shows a more intense emission at 525 nm in PBS (Figures S3 and S4 in the SI).40”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Findingown dataL1 exhibits an acceptable binding affinity for Aβ fibrils, with the higher affinity binding site corresponding to a Ki of 260 nM.
“While L1 exhibits an acceptable binding affinity for Aβ fibrils, with the higher affinity binding site corresponding to a Ki of 260 nM”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFor the Cu-L1 system, pCu values are 6.7 at pH 6.6 and 8.2 at pH 7.4.
“pCu values of 6.7 and 8.2 being determined for the Cu–L1 system at pH 6.6 and 7.4, respectively”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataAlthough a single crystal suitable for X-ray crystallography could be obtained from the reaction mixture of L1 and Zn2+, the isolation of the zinc complexes of L1 or L2 did not lead to pure complexes to allow for their complete characterization.
“Although a single crystal suitable for X-ray crystallography could be obtained from the reaction mixture of L1 and Zn2+, the isolation of the zinc complexes of L1 or L2 did not lead to pure complexes to allow for their complete characterization.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn complex 3, an oxygen and a nitrogen atom from two ligand molecules coordinate to Cu2+, with Cu-O1 and Cu-N1 bond lengths of 1.873(4) and 1.965(4) Å and trans angles of 145.1(2)° and 146.2(2)°, reflecting a distorted square-planar geometry.
“in 3 an oxygen atom and a nitrogen atom from two ligand molecules coordinate to Cu2+. The Cu–O1 and Cu–N1 bond lengths are 1.873(4) and 1.965(4) Å, respectively, and the trans angles O1–Cu1–O1#1 and N1#1–Cu1–N1 are 145.1(2)° and 146.2(2)°, respectively, reflecting a distorted square-planar geometry for Cu2+.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataL1 shows a decrease in ThT fluorescence upon addition of nanomolar amounts, and competitive-binding curve fitting yields a Ki value of 260 ± 40 nM.
“L1 shows a decrease in ThT fluorescence upon the addition of nanomolar amounts. Competitive-binding curve fitting yields a Ki value of 260 ± 40 nM (Figure 5b).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFor L1-Zn2+, the break occurs at ∼0.3 mole fraction of Zn2+, suggesting the formation of a 2:1 L1-Zn2+ complex.
“For L1–Zn2+, the break occurs at ∼0.3 mole fraction of Zn2+, suggesting the formation of a 2:1 L1–Zn2+ complex (Figure S5 in the SI).40”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Findingown dataTitration of L1 with Aβ fibrils shows saturation behavior, and the data fit a one-site binding model with a Kd of 4.70 ± 0.30 μM, suggesting a moderate affinity of L1 for Aβ fibrils.
“Titration of L1 with Aβ fibrils was performed, and a saturation behavior is observed. The data were fitted with a one-site binding model to give a Kd of 4.70 ± 0.30 μM (Figure 5a), which suggests a moderate affinity of L1 for the Aβ fibrils.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataOnly some morphological changes were observed even after 24 h of incubation, and a significant amount of Aβ42 aggregates were still observed by TEM.
“Only some morphological changes were observed even after 24 h of incubation, and a significant amount of Aβ42 aggregates were still observed by TEM (Figure 8, panels 4 and 7).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the absence of metal ions, L1 leads to a low ThT fluorescence intensity, while L2 has a negligible effect on Aβ42 fibrillization, suggesting that L1 can inhibit fibrillization more efficiently than L2.
“In the absence of metal ions, the presence of L1 leads to a low ThT fluorescence intensity, while L2 has a negligible effect on Aβ42 fibrillization, suggesting that L1 can inhibit fibrillization more efficiently than L2.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataNative gel electrophoresis/Western blotting analysis reveals high-molecular-weight soluble Aβ42 species and insoluble aggregates, although to a lesser extent in the presence of L1.
“Native gel electrophoresis/Western blotting analysis reveals high-molecular-weight soluble Aβ42 species and insoluble aggregates, although to a lesser extent in the presence of L1 (Figure 8, lanes 4 and 7).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAlmost no changes were observed in the spectra of both L1 and L2 upon addition of Zn2+, so the corresponding stability constants could not be determined.
“almost no changes were observed in the spectra of both L1 and L2 upon the addition of Zn2+; therefore, the corresponding stability constants could not be determined”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataFor L2, the best fit to the UV-vis titration data was obtained with two pKa values of 3.154(2) and 9.360(1).
“For L2, the best fit to the data was obtained with two pKa values of 3.154(2) and 9.360(1) (Table 2).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe 2:1 complex formation was confirmed by the ESI-MS signal at m/z 658.1 corresponding to [M + H]+, which was further supported by X-ray structural determination.
“The 2:1 complex formation was confirmed by the ESI-MS signal at m/z 658.1 corresponding to [M + H]+, which was further supported by X-ray structural determination (see below).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataEither L1 or L2 in metal-free conditions does not disaggregate preformed Aβ42 fibrils to an appreciable extent.
“First, either L1 or L2 in metal-free conditions does not disaggregate the preformed Aβ42 fibrils to an appreciable extent.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSpectrophotometric titration of L2 in the presence of Cu2+ revealed few spectral changes at micromolar concentrations, and higher concentrations led to precipitation of the L2-Cu2+ complex.
“the spectrophotometric titration of L2 in the presence of Cu2+ revealed few spectral changes at micromolar concentrations, while the use of higher concentrations led to precipitation of the L2–Cu2+ complex”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataComplex 3 has structural properties similar to those of 1, yet it crystallized out in the P2/n space group.
“The copper complex 3 afforded single crystals by Et2O diffusion into a CH2Cl2 solution and has structural properties similar to those of 1, yet it crystallized out in the P2/n space group.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataThe UV-vis spectrum of the L1-Cu2+ complex 1 reveals a d-d transition at ∼700 nm and a more intense band at 540 nm, while a phenolate-to-Cu2+ charge-transfer band is observed at ∼400 nm.
“The UV–vis spectrum of the L1–Cu2+ complex 1 reveals a d–d transition at ∼700 nm and a more intense band at 540 nm, while a phenolate-to-Cu2+ charge-transfer band is observed at ∼400 nm (Figure S6 in the SI).40”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Findingown dataFor complex 2, the Zn2+ ion exhibits a distorted tetrahedral geometry and is coordinated to the benzothiazole nitrogen and phenol oxygen atoms of L1 and two chloride ions.
“For complex 2, the Zn2+ ion exhibits a distorted tetrahedral geometry and is coordinated to the benzothiazole nitrogen and phenol oxygen atoms of L1 and two chloride ions.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataL2 did not show any significant increase in fluorescence intensity in the presence of Aβ fibrils yet replaces ThT from Aβ fibrils and exhibits a Ki value of 15 ± 10 nM, indicating a very strong binding affinity to Aβ fibrils.
“L2 did not show any significant increase in the fluorescence intensity in the presence of Aβ fibrils yet replaces ThT from the Aβ fibrils and exhibits a Ki value of 15 ± 10 nM, indicating a very strong binding affinity to Aβ fibrils (Figure 5c).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataNative gel electrophoresis/Western blotting analysis supports the TEM results for Aβ40, although it is less informative because of the lack of formation of an appreciable amount of soluble Aβ oligomers under any experimental conditions.
“The TEM results are also supported by native gel electrophoresis/Western blotting analysis (Figure S10 in the SI), although this is less informative than in the case of the Aβ42 peptide because of the lack of formation of an appreciable amount of soluble Aβ oligomers under any experimental conditions.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataNative gel/Western blotting shows that while there is a slightly increased amount of low-molecular-weight (10-80 kDa) soluble Aβ42 species, more insoluble aggregates are also observed at the top of the gel.
“This is supported by native gel/Western blotting, which shows that while there is a slightly increased amount of low-molecular-weight (10–80 kDa) soluble Aβ42 species, more insoluble aggregates are also observed at the top of the gel (Figure 8, lanes 5 and 8).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe presence of either L1 or L2 has a dramatic effect on the Cu2+-mediated oligomerization of Aβ42 and promotes the formation of larger Aβ42 aggregates.
“the presence of either L1 or L2 has a dramatic effect on the Cu2+-mediated oligomerization of Aβ42 and promotes the formation of larger Aβ42 aggregates, as observed by TEM (Figure 7, panels 5 and 8).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the presence of Cu2+ and either L1 or L2, a small amount of Aβ40 fibrils are still formed, while the presence of Zn2+ and either L1 or L2 leads to the formation of a larger amount of fibrillar or amorphous aggregates, respectively.
“in the presence of Cu2+ and either L1 or L2, a small amount of Aβ40 fibrils are still formed (Figure S9 in the SI, panels 5 and 8), while the presence of Zn2+ and either L1 or L2 leads to the formation of a larger amount of fibrillar or amorphous aggregates, respectively (Figure S9 in the SI, panels 6 and 9).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe presence of either L1 or L2 in the absence of metal ions does not significantly inhibit Aβ42 aggregation, although some morphological changes were observed for the Aβ42 fibrils.
“The presence of either L1 or L2 in the absence of metal ions does not seem to significantly inhibit Aβ42 aggregation, although some morphological changes were observed for the Aβ42 fibrils (Figure 7, panels 4 and 7)”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAggregation of Aβ42 in the absence of metal ions forms high-molecular-weight oligomers, along with insoluble aggregates.
“aggregation of Aβ42 in the absence of metal ions also forms high-molecular-weight oligomers, along with the insoluble aggregates that are observed at the top of the blot”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn complex 1, Cu2+ is coordinated by an oxygen and a nitrogen atom from two ligand molecules, with Cu-O1 and Cu-N1 bond lengths of 1.980(3) and 1.876(2) Å and trans angles of 153.3(2)° and 154.2(2)°, indicating a distorted square-planar geometry.
“An oxygen atom and a nitrogen atom from two ligand molecules coordinate to Cu2+. The Cu–O1 and Cu–N1 bond lengths are 1.980(3) and 1.876(2) Å, respectively, and the trans angles O1–Cu1–O1#1 and N1#1–Cu1–N1 are 153.3(2)° and 154.2(2)°, respectively, with these parameters suggesting a distorted square-planar geometry for Cu2+.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataIn the presence of Cu2+, either L1 or L2 partially inhibits the Cu2+-promoted formation of small soluble aggregates and allows for enhanced Aβ42 aggregation.
“In the presence of Cu2+, either L1 or L2 partially inhibits the Cu2+-promoted formation of small soluble aggregates and allows for enhanced Aβ42 aggregation (Figure 8, panels 5 and 8 vs panel 2).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
FindingcitationThe UV-vis spectrum of the L2-Cu2+ complex 3 shows characteristic d-d transition bands at 700 and 515 nm as well as a phenolate-to-Cu charge-transfer band at ∼400 nm.
“Similarly, the UV–vis spectrum of the L2–Cu2+ complex 3 shows characteristic d–d transition bands at 700 and 515 nm as well as a phenolate-to-Cu charge-transfer band at ∼400 nm (Figure S7 in the SI).40”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataNo Job's plot analysis could be performed for L2-Cu2+ because of the limited solubility of this complex, while no significant spectral change was observed for the L2-Zn2+ system.
“By contrast to L1, no Job’s plot analysis could be performed for L2–Cu2+ because of the limited solubility of this complex, while no significant spectral change was observed for the L2–Zn2+ system.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataBoth L1 and L2 show no appreciable cell toxicity (>80% cell survival) even up to 20 μM concentration.
“Both L1 and L2 show no appreciable cell toxicity (>80% cell survival) even up to 20 μM concentration.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationExley et al. showed that both sub- and superstoichiometric concentrations of Cu2+ prevent aggregation of Aβ42 into ThT-positive β-sheet-rich amyloid fibrils.
“Exley et al. have used fluorescence assays and transmission electron microscopy (TEM) to show that both sub- and superstoichiometric concentrations of Cu2+ prevent aggregation of Aβ42 into thioflavin T (ThT)-positive β-sheet-rich amyloid fibrils.17−19”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
InterpretationcitationThe first and second pKa values of L1 can be assigned to deprotonation of the nitrogen atoms of the benzothiazole and diethylamino groups, while the largest pKa value is likely due to phenol deprotonation.
“The first and second pKa values can be assigned to deprotonation of the nitrogen atoms of the benzothiazole and diethylamino groups, while the largest pKa value is likely due to phenol deprotonation.25,42”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationCopper, iron, and zinc ions affect Aβ aggregation and lead to formation of reactive oxygen species.
“These metal ions have been shown to affect Aβ aggregation, as well as lead to the formation of reactive oxygen species (ROS).12−16”
Quote in the paperSubstantial claim0 of 5 sources checkedMay combine two claims.
InterpretationreasoningL1 and L2 are expected to cross the BBB.
“suggesting that these BFCs are expected to cross the BBB.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationUnusually high concentrations of copper, iron, and zinc are found within amyloid deposits in AD-affected brains.
“unusually high concentrations of copper, iron, and zinc have been found within the amyloid deposits in AD-affected brains.11”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [11] Lovell, 1998, J. Neurol. Sci. source
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Interpretationown dataThe parent molecule HPB has emission properties similar to those of L2, which suggests that having a diethylamino group in L1 strongly affects its emission properties.
“The parent molecule HPB has emission properties similar to those of L2 (Figure S4 in the SI), which suggests that having a diethylamino group in L1 strongly affects its emission properties.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [40]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe lower pCu values for Cu-L1 compared to HPB are likely due to the strong electron-withdrawing effect of the diethylamine group upon protonation.
“likely because of the strong electron-withdrawing effect of the diethylamine group upon protonation”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll solutions and buffers were prepared using metal-free Millipore water that was treated with Chelex overnight and filtered through a 0.22 μm nylon filter.
“All solutions and buffers were prepared using metal-free Millipore water that was treated with Chelex overnight and filtered through a 0.22 μm nylon filter.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataAll of these in vitro studies suggest that compounds L1 and L2 should control the formation of Cu2+-stabilized soluble Aβ42 species and thus should control their neurotoxicity.
“Overall, all of these in vitro studies suggest that compounds L1 and L2 should control the formation of Cu2+-stabilized soluble Aβ42 species and thus should control their neurotoxicity (vide infra).”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningBecause soluble Aβ42 oligomers are the most neurotoxic species, L1 and L2 are expected to control the neurotoxicity of Aβ42 species in the presence of metal ions.
“Because the soluble Aβ42 oligomers are the most neurotoxic species, these compounds are expected to control the neurotoxicity of Aβ42 species in the presence of metal ions (vide infra).”
Quote in the paperSubstantial claim- Rests on an assumption: Soluble Aβ42 oligomers are the most neurotoxic species.
May combine two claims.
Interpretationown dataThe BFCs described herein bind to metal ions and Aβ fibrils only with moderate affinity.
“However, the BFCs described herein bind to metal ions and Aβ fibrils only with moderate affinity”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationCu2+ by itself is not toxic to N2A cells, but the presence of Cu2+ and either monomeric Aβ42 or soluble Aβ42 oligomers exhibits enhanced cell toxicity.
“while Cu2+ by itself is not toxic to N2A cells, the presence of Cu2+ and either monomeric Aβ42 or soluble Aβ42 oligomers exhibits enhanced cell toxicity.17,18”
Quote in the paperSubstantial claim0 of 2 sources checked
The paper relies on this without support.
ThT is well-known for its amyloid-binding properties because of the 2-phenylbenzothiazole aromatic framework.
“The fluorescent dye ThT is well-known for its amyloid-binding properties because of the 2-phenylbenzothiazole aromatic framework.”
The paper relies on this without support.
The molecular mechanisms of metal–Aβ species interactions, especially for the more neurotoxic Aβ42, are still not completely understood.
“Although many studies have investigated the involvement of metal ions in Aβ aggregation and plaque formation, the molecular mechanisms of metal–Aβ species interactions, especially for the more neurotoxic Aβ42, are still not completely understood.”
The paper relies on this without support.
Specific rather than systemic metal chelation by these compounds is needed to limit side effects.
“However, specific rather than systemic metal chelation by these compounds is needed in order to limit any side effects.”
The paper relies on this without support.
Soluble Aβ42 oligomers are the most neurotoxic species.
“Because the soluble Aβ42 oligomers are the most neurotoxic species”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Conclusion calls L2's fibril affinity moderate despite reporting very strong binding
MajorThe conclusion characterizes both compounds' affinity for Aβ fibrils as only moderate, while the results explicitly characterize L2's measured 15 nM affinity as very strong.
“the BFCs described herein bind to metal ions and Aβ fibrils only with moderate affinity”
“L2 did not show any significant increase in the fluorescence intensity in the presence of Aβ fibrils yet replaces ThT from the Aβ fibrils and exhibits a Ki value of 15 ± 10 nM, indicating a very strong binding affinity to Aβ fibrils”
ThT competition assay concentrations differ
MinorThe methods specify 5 μM Aβ fibrils and 2 μM ThT, but the Figure 5 caption specifies 2 μM Aβ and 1 μM ThT for the competition assays.
“For ThT competition assays, a 5 μM Aβ fibril solution with 2 μM ThT was titrated”
“ThT fluorescence competition assays of Aβ fibrils with (b) L1 and (c) L2 ([Aβ] = 2 μM; [ThT] = 1 μM; λex/λem = 435/485 nm).”
Inhibition experiment is described as treating preformed fibrils
MinorThe results section says the inhibition experiments treated freshly prepared fibrils, but the methods distinguish adding compounds to Aβ solutions for inhibition from treating preformed fibrils for disaggregation.
“For inhibition experiments, freshly prepared Aβ42 fibrils were treated with metal ions, BFCs, or both”
“For disaggregation studies, the preformed Aβ fibrils in the absence or presence of metal ions were treated with BFCs and further incubated for 24 h at 37 °C with constant agitation.”
Copper-treated oligomer results cite the metal-free lanes
MinorThe text cites Figure 9 lanes 9 and 10 for the effect in the presence of Cu2+, but the caption assigns those lanes to metal-free oligomers with L1 and L2. The Cu2+-containing counterparts are lanes 11 and 12.
“Even in the presence of Cu2+, which has been shown to stabilize the soluble Aβ42 oligomers,22 L1 and L2 were able to eliminate the neurotoxicity of soluble Aβ42 oligomers (Figure 9, lanes 9 and 10).”
“(9) Aβ42 oligomers + L1, (10) Aβ42 oligomers + L2, (11) Aβ42 oligomers + L1 + Cu2+, and (12) Aβ42 oligomers + L2 + Cu2+”
Zinc-complex synthesis names the wrong ligand
MinorThe procedure for the L1 zinc complex says it uses L4, whereas the product heading and reported mass spectrum identify the ligand as L1.
“the stirring mixture of L4 (0.050 g, 0.167 mmol) and Et3N”
“Synthesis of [(L1)ZnII(Cl2)](Et3NH) (2)”
Cu-N and Cu-O bond lengths are reversed
MinorFor complex 1, the text assigns 1.980 Å to Cu-O and 1.876 Å to Cu-N; the Figure 4 caption assigns those same lengths to Cu-N and Cu-O, respectively.
“The Cu–O1 and Cu–N1 bond lengths are 1.980(3) and 1.876(2) Å, respectively”
“1, Cu1–N1 1.980(3), Cu1–O1 1.876(2)”
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
Cites a retracted work: 10.1038/nature04533
InfoThe cited work was retracted on 2024-06-24 (notice 10.1038/s41586-024-07691-8), not before this paper was published (2014-10-21).
Cited work 10.1038/nature04533 · retracted 2024-06-24 · notice 10.1038/s41586-024-07691-8 · this paper published 2014-10-21
“Lesne, 2006, Nature, 440, 352, 10.1038/nature04533”
Cites
1 retracted
RETRACTED ARTICLE: A specific amyloid-β protein assembly in the brain impairs memory
Lesné, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., & Ashe, K. H. (2006) · Nature · doi:10.1038/nature04533 · Cited by 2,769 · see citing works
RetractedSheldrick, G. M. (2007) · Acta Crystallographica Section A Foundations of Crystallography · doi:10.1107/s0108767307043930 · Cited by 87,861 · see citing works
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139 · see citing works
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359 · see citing works
Global prevalence of dementia: a Delphi consensus study
Ferri, C. P., Prince, M. J., Brayne, C., Brodaty, H., Fratiglioni, L., Ganguli, M., Hall, K. S., Hasegawa, K., Hendrie, H. C., Huang, Y., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67889-0 · Cited by 5,336 · see citing works
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · see citing works
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506 · see citing works
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120 · see citing works
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938 · see citing works
Alderighi, L., Gans, P., Ienco, A., Peters, D., Sabatini, A., & Vacca, A. (1999) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(98)00260-4 · Cited by 1,671 · see citing works
Rapid induction of Alzheimer A beta amyloid formation by zinc
Bush, A., Pettingell, W., Multhaup, G., d Paradis, M., Vonsattel, J., Gusella, J., Beyreuther, K., Masters, C., & Tanzi, R. (1994) · Science · doi:10.1126/science.8073293 · Cited by 1,522 · see citing works
Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability
Dahlgren, K. N., Manelli, A. M., Stine, W. B., Baker, L. K., Krafft, G. A., & LaDu, M. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201750200 · Cited by 1,452 · see citing works
[18] Quantification of β-sheet amyloid fibril structures with thioflavin T
LeVine, H. (1999) · Methods in Enzymology · doi:10.1016/s0076-6879(99)09020-5 · Cited by 1,365 · see citing works
Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123 · see citing works
Structural conversion of neurotoxic amyloid-β1–42 oligomers to fibrils
Ahmed, M., Davis, J., Aucoin, D., Sato, T., Ahuja, S., Aimoto, S., Elliott, J. I., Van Nostrand, W. E., & Smith, S. O. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1799 · Cited by 1,111 · see citing works
Gong, Y., Chang, L., Viola, K. L., Lacor, P. N., Lambert, M. P., Finch, C. E., Krafft, G. A., & Klein, W. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834302100 · Cited by 1,061 · see citing works
Atwood, C. S., Moir, R. D., Huang, X., Scarpa, R. C., Bacarra, N. M. E., Romano, D. M., Hartshorn, M. A., Tanzi, R. E., & Bush, A. I. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.21.12817 · Cited by 1,009 · see citing works
Cu(II) Potentiation of Alzheimer Aβ Neurotoxicity
Huang, X., Cuajungco, M. P., Atwood, C. S., Hartshorn, M. A., Tyndall, J. D. A., Hanson, G. R., Stokes, K. C., Leopold, M., Multhaup, G., Goldstein, L. E., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.52.37111 · Cited by 762 · see citing works
Alzheimer's Disease: From Pathology to Therapeutic Approaches
Jakob‐Roetne, R., & Jacobsen, H. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200802808 · Cited by 626 · see citing works
Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice
McGowan, E., Pickford, F., Kim, J., Onstead, L., Eriksen, J., Yu, C., Skipper, L., Murphy, M. P., Beard, J., Das, P., et al. (2005) · Neuron · doi:10.1016/j.neuron.2005.06.030 · Cited by 565 · see citing works
Self-citationAβ toxicity in Alzheimer’s disease: globular oligomers (ADDLs) as new vaccine and drug targets
Klein, W. L. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(02)00050-5 · Cited by 541 · see citing works
[27] Determination of binding stoichiometry by the continuous variation method: The job plot
Huang, C. Y. (1982) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(82)87029-8 · Cited by 536 · see citing works
Kuperstein, I., Broersen, K., Benilova, I., Rozenski, J., Jonckheere, W., Debulpaep, M., Vandersteen, A., Segers‐Nolten, I., Van Der Werf, K., Subramaniam, V., et al. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.211 · Cited by 532 · see citing works
Klunk, W. E., Wang, Y., Huang, G.-F., Debnath, M. L., Holt, D. P., & Mathis, C. A. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01232-2 · Cited by 457 · see citing works
Causes of oxidative stress in Alzheimer disease
Zhu, X., Su, B., Wang, X., Smith, M. A., & Perry, G. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7218-4 · Cited by 336 · see citing works
Scott, L. E., & Orvig, C. (2009) · Chemical Reviews · doi:10.1021/cr9000176 · Cited by 332 · see citing works
Metal complexing agents as therapies for Alzheimer’s disease
Bush, A. I. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00120-3 · Cited by 310 · see citing works
House, E., Collingwood, J., Khan, A., Korchazkina, O., Berthon, G., & Exley, C. (2004) · Journal of Alzheimer's Disease · doi:10.3233/jad-2004-6310 · Cited by 294 · see citing works
Choi, J.-S., Braymer, J. J., Nanga, R. P. R., Ramamoorthy, A., & Lim, M. H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006091107 · Cited by 264 · see citing works
Metal-associated amyloid-β species in Alzheimer's disease
Pithadia, A. S., & Lim, M. H. (2012) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2012.01.016 · Cited by 259 · see citing works
Hureau, C., & Faller, P. (2009) · Biochimie · doi:10.1016/j.biochi.2009.03.013 · Cited by 259 · see citing works
Metal based neurodegenerative diseases—From molecular mechanisms to therapeutic strategies
Crichton, R. R., Dexter, D. T., & Ward, R. J. (2008) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2007.10.019 · Cited by 252 · see citing works
Lockhart, A., Ye, L., Judd, D. B., Merritt, A. T., Lowe, P. N., Morgenstern, J. L., Hong, G., Gee, A. D., & Brown, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412056200 · Cited by 213 · see citing works
Rodríguez-Rodríguez, C., Sánchez de Groot, N., Rimola, A., Álvarez-Larena, Á., Lloveras, V., Vidal-Gancedo, J., Ventura, S., Vendrell, J., Sodupe, M., & González-Duarte, P. (2009) · Journal of the American Chemical Society · doi:10.1021/ja806062g · Cited by 210 · see citing works
Small Molecule Modulators of Copper-Induced Aβ Aggregation
Hindo, S. S., Mancino, A. M., Braymer, J. J., Liu, Y., Vivekanandan, S., Ramamoorthy, A., & Lim, M. H. (2009) · Journal of the American Chemical Society · doi:10.1021/ja907045h · Cited by 203 · see citing works
Bifunctional Compounds for Controlling Metal-Mediated Aggregation of the Aβ<sub>42</sub>Peptide
Sharma, A. K., Pavlova, S. T., Kim, J., Finkelstein, D., Hawco, N. J., Rath, N. P., Kim, J., & Mirica, L. M. (2012) · Journal of the American Chemical Society · doi:10.1021/ja210588m · Cited by 202 · see citing works
Self-citationStorr, T., Merkel, M., Song-Zhao, G. X., Scott, L. E., Green, D. E., Bowen, M. L., Thompson, K. H., Patrick, B. O., Schugar, H. J., & Orvig, C. (2007) · Journal of the American Chemical Society · doi:10.1021/ja068965r · Cited by 156 · see citing works
Rodríguez-Rodríguez, C., Telpoukhovskaia, M., & Orvig, C. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.03.008 · Cited by 151 · see citing works
Preliminary studies of a novel bifunctional metal chelator targeting Alzheimer's amyloidogenesis
Dedeoglu, A., Cormier, K., Payton, S., Tseitlin, K. A., Kremsky, J. N., Lai, L., Li, X., Moir, R. D., Tanzi, R. E., Bush, A. I., et al. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.08.016 · Cited by 141 · see citing works
The effect of Cu2+ and Zn2+ on the Aβ42 peptide aggregation and cellular toxicity
Sharma, A. K., Pavlova, S. T., Kim, J., Kim, J., & Mirica, L. M. (2013) · Metallomics · doi:10.1039/c3mt00161j · Cited by 135 · see citing works
Self-citationZhang, Y., Rempel, D. L., Zhang, J., Sharma, A. K., Mirica, L. M., & Gross, M. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309175110 · Cited by 118 · see citing works
Self-citationTalmard, C., Bouzan, A., & Faller, P. (2007) · Biochemistry · doi:10.1021/bi701355j · Cited by 111 · see citing works
Exley, C. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-102-305 · Cited by 107 · see citing works
Mold, M., Ouro-Gnao, L., Wieckowski, B. M., & Exley, C. (2013) · Scientific Reports · doi:10.1038/srep01256 · Cited by 101 · see citing works
Scott, L. E., Telpoukhovskaia, M., Rodríguez-Rodríguez, C., Merkel, M., Bowen, M. L., Page, B. D. G., Green, D. E., Storr, T., Thomas, F., Allen, D. D., et al. (2011) · Chem. Sci. · doi:10.1039/c0sc00544d · Cited by 68 · see citing works
Braymer, J. J., DeToma, A. S., Choi, J.-S., Ko, K. S., & Lim, M. H. (2011) · International Journal of Alzheimer’s Disease · doi:10.4061/2011/623051 · Cited by 50 · see citing works
Copper Abolishes the β-Sheet Secondary Structure of Preformed Amyloid Fibrils of Amyloid-β42
House, E., Mold, M., Collingwood, J., Baldwin, A., Goodwin, S., & Exley, C. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1235 · Cited by 45 · see citing works
Reactivity of Diphenylpropynone Derivatives Toward Metal-Associated Amyloid-β Species
Pithadia, A. S., Kochi, A., Soper, M. T., Beck, M. W., Liu, Y., Lee, S., DeToma, A. S., Ruotolo, B. T., & Lim, M. H. (2012) · Inorganic Chemistry · doi:10.1021/ic302084g · Cited by 38 · see citing works
Liu, Y., Kochi, A., Pithadia, A. S., Lee, S., Nam, Y., Beck, M. W., He, X., Lee, D., & Lim, M. H. (2013) · Inorganic Chemistry · doi:10.1021/ic400851w · Cited by 30 · see citing works
Exley, C. (2012) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2012.08.012 · Cited by 2 · see citing works
Flagged first, then by citations
Research works printed but not linked: 3
- Braymer, 2011, Int. J. Alzheimer’s Dis., 2011, 623051, 10.4061/2011/623051 · DOI · Paper page
- Gans, 1999, Ann. Chim., 45
- Haass, 2007, Nat. Rev. Mol. Cell Biol., 8, 101, 10.1038/nrm2101 · DOI · Paper page
Cited by
Sorted by citations
Copper Toxicity Links to Pathogenesis of Alzheimer’s Disease and Therapeutics Approaches
Ijaz, H. W., Wang, W., & Lang, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207660 · Cited by 146 · see citing works
“It is now undeniable that the next generation of therapies should have the ability to target the different causes of disease progression at the same time [287].”
BackgroundRana, M., & Sharma, A. K. (2018) · Metallomics · doi:10.1039/c8mt00203g · Cited by 113 · see citing works
Self-citationSun, L., Cho, H.-J., Sen, S., Arango, A. S., Huynh, T. T., Huang, Y., Bandara, N., Rogers, B. E., Tajkhorshid, E., & Mirica, L. M. (2021) · Journal of the American Chemical Society · doi:10.1021/jacs.1c05470 · Cited by 100 · see citing works
Self-citationMulti-target-directed phenol–triazole ligands as therapeutic agents for Alzheimer's disease
Jones, M. R., Mathieu, É., Dyrager, C., Faissner, S., Vaillancourt, Z., Korshavn, K. J., Lim, M. H., Ramamoorthy, A., Yong, V. W., Tsutsui, S., et al. (2017) · Chemical Science · doi:10.1039/c7sc01269a · Cited by 96 · see citing works
Xu, P., Zhang, M., Sheng, R., & Ma, Y. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.12.045 · Cited by 92 · see citing works
Self‐Assembly of Tyrosine into Controlled Supramolecular Nanostructures
Ménard‐Moyon, C., Venkatesh, V., Krishna, K. V., et al. (2015) · Chemistry - A European Journal · doi:10.1002/chem.201502076 · Cited by 91 · see citing works
Chinna Ayya Swamy, P., Jayaraj, A., Swathi, N. P., et al. (2021) · ACS Omega · doi:10.1021/acsomega.1c02855 · Cited by 86 · see citing works
Bandara, N., Sharma, A. K., Krieger, S., Schultz, J. W., Han, B. H., Rogers, B. E., & Mirica, L. M. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.7b05937 · Cited by 76 · see citing works
Self-citationSharma, A. K., Schultz, J. W., Prior, J. T., Rath, N. P., & Mirica, L. M. (2017) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.7b01883 · Cited by 60 · see citing works
Self-citationHuang, Y., Cho, H.-J., Bandara, N., Sun, L., Tran, D., Rogers, B. E., & Mirica, L. M. (2020) · Chemical Science · doi:10.1039/d0sc02641g · Cited by 58 · see citing works
Self-citationCho, H., Sharma, A. K., Zhang, Y., Gross, M. L., & Mirica, L. M. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00114 · Cited by 53 · see citing works
Self-citationZhang, Q., Hu, X., Wang, W., & Yuan, Z. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.5b01603 · Cited by 50 · see citing works
Cho, H.-J., Huynh, T. T., Rogers, B. E., & Mirica, L. M. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2014058117 · Cited by 46 · see citing works
Self-citationSun, L., Sharma, A. K., Han, B.-H., & Mirica, L. M. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00376 · Cited by 45 · see citing works
Self-citationAzo-dyes based small bifunctional molecules for metal chelation and controlling amyloid formation
Rana, M., Cho, H., Roy, T. K., Mirica, L. M., & Sharma, A. K. (2017) · Inorganica Chimica Acta · doi:10.1016/j.ica.2017.11.029 · Cited by 40 · see citing works
Self-citationMolecular Design for Dual Modulation Effect of Amyloid Protein Aggregation
Zhu, L., Song, Y., Cheng, P.-N., & Moore, J. S. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b01651 · Cited by 37 · see citing works
Pareek, A., Dada, R., Rana, M., Sharma, A. K., & Yaragorla, S. (2016) · RSC Advances · doi:10.1039/c6ra17411f · Cited by 34 · see citing works
Self-citationRhodamine-Based Metal Chelator: A Potent Inhibitor of Metal-Catalyzed Amyloid Toxicity
Pradhan, K., Das, G., Kar, C., Mukherjee, N., Khan, J., Mahata, T., Barman, S., & Ghosh, S. (2020) · ACS Omega · doi:10.1021/acsomega.0c02235 · Cited by 30 · see citing works
A closer look at amyloid ligands, and what they tell us about protein aggregates.
Chisholm, T., & Hunter, C. A. (2023) · Chemical Society Reviews · doi:10.1039/d3cs00518f · Cited by 15 · see citing works
Mei, W.-W., Ji, S.-S., Xiao, W., Wang, X., Jiang, C., Ma, W.-Q., Zhang, H., Gong, J., & Guo, Y. (2017) · Monatshefte für Chemie - Chemical Monthly · doi:10.1007/s00706-017-1993-x · Cited by 26 · see citing works
Meng, J., Zhang, H., Dong, X., Liu, F., & Sun, Y. P. (2018) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2018.01.012 · Cited by 25 · see citing works
Ligands for Protein Fibrils of Amyloid-β, α-Synuclein, and Tau
Chisholm, T. S., & Hunter, C. A. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00838 · Cited by 24 · see citing works
Yaragorla, S., Dada, R., Singh, G., et al. (2016) · ChemistrySelect · doi:10.1002/slct.201601349 · Cited by 21 · see citing works
Self-citationWang, D., Zhang, Q., Hu, X., Wang, W., Zhu, X., & Yuan, Z. (2017) · Acta Biomaterialia · doi:10.1016/j.actbio.2017.10.039 · Cited by 21 · see citing works
Copper chelating cyclic peptidomimetic inhibits Aβ fibrillogenesis
Kalita, S., Kalita, S., Kawa, A. H., Shill, S., Gupta, A., Kumar, S., & Mandal, B. (2022) · RSC Medicinal Chemistry · doi:10.1039/d2md00019a · Cited by 20 · see citing works
Kargar, H., Ashfaq, M. H., Fallah‐Mehrjardi, M., et al. (2022) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2022.132905 · Cited by 20 · see citing works
Spiegel, M., Marino, T., Prejanò, M., & Russo, N. (2022) · Physical Chemistry Chemical Physics · doi:10.1039/d2cp01918c · Cited by 19 · see citing works
Vetrova, E. V., Tupaeva, I. O., Sayapin, Y. A., et al. (2020) · Dyes and Pigments · doi:10.1016/j.dyepig.2020.108417 · Cited by 19 · see citing works
Xie, B., Liu, F., Dong, X., Wang, Y., Liu, M., & Sun, Y. P. (2017) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2017.03.009 · Cited by 18 · see citing works
New Hydroxyquinoline‐Based Derivatives as Potent Modulators of Amyloid‐β Aggregations
Fu, C., Hsu, L., Liao, Y., & Hu, M. (2016) · Archiv der Pharmazie · doi:10.1002/ardp.201500453 · Cited by 16 · see citing works
Rana, M., Pareek, A., Bhardwaj, S., Arya, G., Nimesh, S., Arya, H., Bhatt, T. K., Yaragorla, S., & Sharma, A. K. (2020) · RSC Advances · doi:10.1039/d0ra05172a · Cited by 17 · see citing works
Self-citationMetals in Imaging of Alzheimer’s Disease
Krasnovskaya, O. O., Spector, D. V., Zlobin, A., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239190 · Cited by 15 · see citing works
“Conjugates containing Aβ-binding and metal-chelating moieties were found to modulate the aggregation of Aβ42 species [49,50].”
BackgroundXie, B., Dong, X., Wang, Y., et al. (2015) · Langmuir · doi:10.1021/acs.langmuir.5b01108 · Cited by 15 · see citing works
Mallesh, R., Khan, J., Gharai, P. K., Ghosh, S., Garg, S., Arshi, M. U., & Ghosh, S. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.2c00787 · Cited by 14 · see citing works
Huang, Y., Huynh, T. T., Sun, L., Hu, C., Wang, Y.-C., Rogers, B. E., & Mirica, L. M. (2022) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.2c00621 · Cited by 15 · see citing works
Self-citationJadhao, M., Das, C., Rawat, A., Kumar, H., Joshi, R., Maiti, S., & Ghosh, S. K. (2016) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-016-1407-2 · Cited by 14 · see citing works
Xie, B., Zhang, H., Li, X., Dong, X., & Sun, Y. P. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00128 · Cited by 12 · see citing works
Zimou, O., Malek, B., Hallaoui, A. E., et al. (2018) · BULLETIN OF CHEMICAL REACTION ENGINEERING AND CATALYSIS · doi:10.9767/bcrec.14.2.2976.238-246 · Cited by 12 · see citing works
“They also found their application as indicators of Alzheimer's disease [10], and they are served as reactive and hair dyes [11-12].”
BackgroundPino‐Cuevas, A., Raposinho, P., Fernandes, C., Paulo, A., Abram, U., Carballo, R., & Vázquez-López, E. M. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0013 · Cited by 8 · see citing works
Rana, M., Terpstra, K., GUTIERREZ, C. G., Xu, K., Arya, H., Bhatt, T. K., Mirica, L. M., & Sharma, A. K. (2024) · Chemistry - A European Journal · doi:10.1002/chem.202402748 · Cited by 8 · see citing works
Self-citationTurn-on fluorescent sensors for Cu-rich amyloid β peptide aggregates
Huang, Y., Sun, L., & Mirica, L. M. (2022) · Sensors & Diagnostics · doi:10.1039/d2sd00028h · Cited by 7 · see citing works
Self-citationA small bifunctional chelator that modulates Aβ42 aggregation
Zhang, C., Gomes, L. M., Zhang, T., & Storr, T. (2017) · Canadian Journal of Chemistry · doi:10.1139/cjc-2017-0623 · Cited by 7 · see citing works
Rational Design of a Cu Chelator That Mitigates Cu‐Induced ROS Production by Amyloid Beta
Mitra, S., Talukdar, K., Prasad, P., Misra, S. K., Khan, S. I., Sharp, J. S., Jurss, J. W., & Chakraborty, S. (2021) · ChemBioChem · doi:10.1002/cbic.202100485 · Cited by 6 · see citing works
Kumar, S., Arumugam, S., Schwarz, B. C., et al. (2023) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.202200774 · Cited by 6 · see citing works
Research Progress on Functional Food on Prevention of Alzheimer Disease
刘, 睿. (2019) · Hans Journal of Food and Nutrition Science · doi:10.12677/hjfns.2019.81007 · Cited by 2 · see citing works
Zhang, H., Ya, J., Liao, X., Du, X., Zhao, C., Ren, J., & Qu, X. (2025) · Small · doi:10.1002/smll.202509547 · Cited by 1 · see citing works
Malpani, P., Rana, M., Morda, U., & Sharma, A. K. (2026) · ChemistrySelect · doi:10.1002/slct.202504275 · Cited by 1 · see citing works
Self-citationWei, S., Li, J., Yu, B., et al. (2026) · Angewandte Chemie · doi:10.1002/ange.3751232
- Authors
- Sharma, A. K., Kim, J., Prior, J. T., Hawco, N. J., Rath, N. P., Kim, J., & Mirica, L. M.
- Affiliations
- Washington University in St. Louis (US)
- University of Missouri–St. Louis (US)
- Corresponding author
- Mirica, Liviu M.
- Venue
- Inorganic Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2014-10-21
- Volume
- 53
- Issue
- 21
- Pages
- 11367-11376
- ISSN
- 0020-1669 (ISSN-L)
- 1520-510X
- PMC
- PMC4220862
- OpenAlex
- W2330115237
- Semantic Scholar
- 630983fd049ae2608e213d551f53ffd8b361e8fa
- Cited by
- 48
- References
- 51
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 5 · 2021: 3 · 2020: 9 · 2019: 2 · 2018: 3 · 2017: 9 · 2016: 6 · 2015: 3
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Inorganic Chemistry (publishedVersion, other-oa)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (submittedVersion)
- PubMed Central (submittedVersion)
- Funders
- National Institute on Aging (NIH P50-AG05681)
- National Institute of Neurological Disorders and Stroke (NIH P30NS69329)
- Alfred P. Sloan Foundation (NA)
- Alzheimer's Association (NIRP-12-259199)
- Oak Ridge Associated Universities (NA)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Pharmacology › Cholinesterase and Neurodegenerative Diseases
- Physical Sciences › Chemistry › Spectroscopy › Molecular Sensors and Ion Detection
- Keywords
- amyloid-beta, Alzheimer's disease, benzothiazole ligands, thioflavin T, Aβ42 oligomers, metal complex stability constants, amyloid fibril binding
- MeSH terms
- Animals, Cell Survival, Chelating Agents, Clioquinol, Models, Molecular, Molecular Structure, Amyloid beta-Peptides, Crystallography, X-Ray, Cell Line, Tumor, Mice, Protein Aggregation, Pathological, Protein Aggregates
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-17.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-17.
Cited sources are checked by gpt-6-sol.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review